Oral administration of 6.5 x 109 colony forming units (CFUs) of Lactobacillus casei Shirota in patients with metabolic syndrome did not influence lipopolysaccharide-binding protein (LBP) compared with controls (73). Here, LBP is linked to metabolic syndrome.